"In accordance with Nasdaq listing rules, the Company has been provided an initial period of 180 calendar days, or until March 18, 2020 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. If, at any time during this 180-day period, the closing bid price of the Company’s common stock is at least $1.00 for a minimum of 10 consecutive business days, the Staff will provide the Company written confirmation of compliance with the Minimum Bid Price Requirement and the matter will be closed. If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180 calendar day compliance period."
https://fintel.io/doc/sec-ghsi-8k-guardion-health-sciences-2019-september-26-18165
Recent GHSI News
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 • GlobeNewswire Inc. • 03/29/2024 10:15:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:19:56 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/31/2024 10:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:18:13 PM
- Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc. • GlobeNewswire Inc. • 01/30/2024 11:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:26 PM
- Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 • GlobeNewswire Inc. • 11/13/2023 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:48:46 PM
- Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 • GlobeNewswire Inc. • 08/14/2023 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 12:00:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 12:47:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:20:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:00:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:00:38 PM
- Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer • GlobeNewswire Inc. • 05/30/2023 12:00:00 PM
- Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 • GlobeNewswire Inc. • 05/15/2023 12:15:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM